Alison Estabrook

3.1k citations

46 papers · 2.1k indexed · 1 hit paper · h-index 22

Cancer Research top 1%
Pathology and Forensic Medicine top 1%
Surgery top 5%
Oncology top 5%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Paul Ian Tartter Sharon R. Smith Ira J. Bleiweiss Aye Moe Thu Jeffrey J. Kirshner George W. Sledge Clifford A. Hudis Richard E. Fine
Topics: Breast Cancer Treatment Studies (20 papers)Breast Lesions and Carcinomas (15 papers)Monoclonal and Polyclonal Antibodies Research (11 papers)
Cited by: Cancer Research Pathology and Forensic Medicine Dermatology
Journals: Journal of Clinical Investigation Journal of Clinical Oncology Annals of Surgery
Partner nations: United States Israel Switzerland

In The Last Decade

Alison Estabrook

46 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

2001 616 citations Alison Estabrook et al. profile →

Peers

Countries citing papers authored by Alison Estabrook

Since Specialization

Citations

This map shows the geographic impact of Alison Estabrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Estabrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Estabrook more than expected).

Fields of papers citing papers by Alison Estabrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Estabrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Estabrook. The network helps show where Alison Estabrook may publish in the future.

Co-authorship network of co-authors of Alison Estabrook

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Estabrook. A scholar is included among the top collaborators of Alison Estabrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Estabrook. Alison Estabrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short-term, postoperative breast cancer outcomes in patients with advanced age 2016 ·The American Journal of Surgery ·(unknown),Nicole Ilonzo,(unknown),(unknown),Alison Estabrook,Aye Moe Thu	12
2	Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients 2008 ·The American Journal of Surgery ·Aye Moe Thu,(unknown),(unknown),(unknown),(unknown),Alison Estabrook,(unknown),Paul Ian Tartter	95
3	Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? 2008 ·The American Journal of Surgery ·(unknown),(unknown),Alison Estabrook,Sharon R. Smith,Susan K. Boolbol,Sheldon Feldman,Michael P. Osborne,Kwadwo Boachie‐Adjei,(unknown),Paul Ian Tartter	107
4	The signficance of surgical margins for patients with atypical ductal hyperplasia 2006 ·The American Journal of Surgery ·(unknown),Paul Ian Tartter,Sharon R. Smith,Alison Estabrook	16
5	The Consequence of Multiple Re-Excisions to Obtain Clear Lumpectomy Margins in Breast Cancer Patients 2005 ·Annals of Surgical Oncology ·Tehillah S. Menes,Paul Ian Tartter,Ira J. Bleiweiss,James Godbold,Alison Estabrook,Sharon R. Smith	74
6	Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers 2004 ·Annals of Surgical Oncology ·Mahmoud El‐Tamer,Donna Russo,Andrea B. Troxel,(unknown),(unknown),Alison Estabrook,(unknown),Freya Schnabel,Mahesh Mansukhani	47
7	Sulfotransferase 1A1 (SULT1A1) Polymorphism, PAH-DNA Adduct Levels in Breast Tissue and Breast Cancer Risk in a Case-Control Study 2003 ·Breast Cancer Research and Treatment ·Deliang Tang,Andrew Rundle,LaVerne A. Mooney,(unknown),Freya Schnabel,Alison Estabrook,A. Brown Kelly,Richard B. Levine,(unknown),Frederica P. Perera	40
8	The Significance of Atypical Lobular Hyperplasia at Percutaneous Breast Biopsy 2003 ·The Breast Journal ·(unknown),Paul Ian Tartter,(unknown),(unknown),Sharon R. Smith,Alison Estabrook	56
9	Touch Preparation or Frozen Section for Intraoperative Detection of Sentinel Lymph Node Metastases From Breast Cancer 2003 ·Annals of Surgical Oncology ·Tehillah S. Menes,Paul Ian Tartter,Howard H. Mizrachi,Sharon R. Smith,Alison Estabrook	58
10	Breast conservation in patients with multiple ipsilateral synchronous cancers 2003 ·Journal of the American College of Surgeons ·Jess L. Kaplan,(unknown),Paul Ian Tartter,Ira J. Bleiweiss,Alison Estabrook,Sharon R. Smith	39
11	Polymorphisms in the DNA Repair Enzyme XPD are Associated with Increased Levels of PAH–DNA Adducts in a Case-Control Study of Breast Cancer 2002 ·Breast Cancer Research and Treatment ·Deliang Tang,(unknown),Andrew Rundle,Senqing Chen,David H. Phillips,(unknown),(unknown),Freya Schnabel,Alison Estabrook,Frederica P. Perera	83
12	Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer* 2002 ·Journal of Surgical Oncology ·Csaba Gajdos,Paul Ian Tartter,Alison Estabrook,(unknown),Shabnam Jaffer,Ira J. Bleiweiss	67
13	The prognostic significance of Gail model risk factors for women with breast cancer 2002 ·The American Journal of Surgery ·Paul Ian Tartter,Csaba Gajdos,Sharon R. Smith,Alison Estabrook,Alfred Rademaker	10
14	Short-Term Outcome of Chronic Immunosuppression on the Development of Breast Lesions in Premenopausal Heart and Lung Transplant Patients 1998 ·Journal of Surgical Research ·Anne Campbell,Nader Moazami,Beth Ann Ditkoff,(unknown),Alison Estabrook,Freya Schnabel	10
15	Immediate Breast Reconstruction in Patients with Locally Advanced Disease 1997 ·Annals of Plastic Surgery ·Mark R. Sultan,Michael L. Smith,Alison Estabrook,Freya Schnabel,Davinder Singh	39
16	Importance of Adequate Staging and of Hormone Receptors in Women Older Than Age 70 With Breast Cancer 1992 ·Annals of Surgery ·(unknown),Alison Estabrook,(unknown),Robert R. Sciacca	12
17	Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons 1992 ·Cancer Immunology Immunotherapy ·(unknown),Maya Gutierrez,Hongping Jiang,Alison Estabrook,S. G. Waxman,Paul B. Fisher	8
18	Tumor localization in nude mice bearing human breast carcinoma xenografts using 111In-DTPA conjugates of monoclonal antibodies 1991 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·Shrishailam Yemul,(unknown),David W. Seldin,(unknown),(unknown),Ricardo Mesa‐Tejada,Alison Estabrook	2
19	Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells 1990 ·Cancer Immunology Immunotherapy ·Shrishailam Yemul,Carole L. Berger,M Katz,Alison Estabrook,Richard L. Edelson,Hagan Bayley	11
20	Stage I and II breast carcinoma: treatment with limited surgery and radiation therapy versus mastectomy. 1990 ·Radiology ·Ritsuko Komaki,James D. Cox,Sven J. Kister,F. E. Gump,Alison Estabrook	5

About Alison Estabrook

Alison Estabrook is a scholar working on Cancer Research, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (15 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). The work is most often cited by research in Cancer Research (1.3k citations), Pathology and Forensic Medicine (905 citations) and Dermatology (226 citations). Alison Estabrook has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Paul Ian Tartter, Sharon R. Smith, Ira J. Bleiweiss, Aye Moe Thu, Jeffrey J. Kirshner, George W. Sledge, Clifford A. Hudis, Richard E. Fine, Gini F. Fleming and Stephen B. Edge. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact